Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cross-Sectional Research01:50

Cross-Sectional Research

In cross-sectional research, a researcher compares multiple segments of the population at the same time. If they were interested in people's dietary habits, the researcher might directly compare different groups of people by age. Instead of following a group of people for 20 years to see how their dietary habits changed from decade to decade, the researcher would study a group of 20-year-old individuals and compare them to a group of 30-year-old individuals and a group of 40-year-old...
Cluster Sampling Method01:20

Cluster Sampling Method

Appropriate sampling methods ensure that samples are drawn without bias and accurately represent the population. Because measuring the entire population in a study is not practical, researchers use samples to represent the population of interest.
To choose a cluster sample, divide the population into clusters (groups) and then randomly select some of the clusters. All the members from these clusters are in the cluster sample. For example, if you randomly sample four departments from your...
One-Way ANOVA: Unequal Sample Sizes01:15

One-Way ANOVA: Unequal Sample Sizes

One-way ANOVA can be performed on three or more samples of unequal sizes. However, calculations get complicated when sample sizes are not always the same. So, while performing ANOVA with unequal samples size, the following equation is used:
Multiple Comparison Tests01:13

Multiple Comparison Tests

Multiple comparison test, abbreviated as MCT, is a post hoc analysis generally performed after comparing multiple samples with one or more tests. An MCT will help identify a significantly different sample among multiple samples or a factor among multiple factors.
It would be easy to compare two samples using a significance alpha level of 0.05. In other words, there is only one sample pair to be compared. However, it would be difficult to identify a significantly different sample if the number...
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Practice Patterns and Overall Survival for Octogenarians with Triple Negative Breast Cancer Treated at Accredited Cancer Centers in the USA.

Annals of surgical oncology·2026
Same author

ASO Visual Abstract: Practice Patterns and Overall Survival for Octogenarians with Triple-Negative Breast Cancer Treated at Accredited Cancer Centers in the United States.

Annals of surgical oncology·2026
Same author

Redesigning a Culture of Safety and High Reliability-Advancing our Patient Safety Organizational Learning System Through the Kirkpatrick Framework.

Joint Commission journal on quality and patient safety·2026
Same author

Clinical Outcomes of Surgical Options for Base-of-Thumb Arthritis: A Systematic Review and Network Meta-Analysis.

The Journal of hand surgery·2026
Same author

Scleredema of Buschke: 2 cases with a remarkable response to treatment of the underlying paraprotein.

JAAD case reports·2026
Same author

'Visual Literacy: Seeing the Skin' course effect on clinician observational and descriptive skills in skin of colour and white skin.

Clinical and experimental dermatology·2026

Related Experiment Video

Updated: Jul 10, 2026

Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits
08:27

Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits

Published on: September 27, 2019

Comparing excess costs across multiple corporate populations.

Douglas Wright1, Laura Adams, Marshall J Beard

  • 1Health Management Research Center, University of Michigan, Ann Arbor, Michigan 48104-1688, USA.

Journal of Occupational and Environmental Medicine
|September 9, 2004
PubMed
Summary

Higher health risk levels significantly increase medical costs. Excess medical costs due to increased health risk account for a substantial portion of annual expenses, justifying health promotion programs.

More Related Videos

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

Related Experiment Videos

Last Updated: Jul 10, 2026

Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits
08:27

Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits

Published on: September 27, 2019

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

Area of Science:

  • Health Economics
  • Occupational Health
  • Preventive Medicine

Background:

  • Medical costs are a significant concern for corporations.
  • Understanding the drivers of healthcare spending is crucial for cost containment.
  • Health risk assessments (HRAs) can identify individuals at higher risk.

Purpose of the Study:

  • To investigate the correlation between health risk levels and charged medical costs.
  • To quantify the excess medical costs incurred by high-risk individuals compared to low-risk individuals.
  • To determine the proportion of medical costs attributable to elevated health risks.

Main Methods:

  • Analysis of two years of medical claims data from six corporations.
  • Inclusion of 165,770 employees, with 21,124 participants in a health risk assessment (HRA).
  • Comparison of medical costs between HRA participants and non-participants, stratified by risk level.

Main Results:

  • Medical costs demonstrated a positive correlation with increasing health risk levels.
  • No significant inter-company variations in cost ratios were observed within specific risk levels.
  • Excess medical costs attributed to elevated risk ranged from 15.0% to 30.8% for HRA participants and 23.8% to 38.3% for the total study population.
  • Consistent cost patterns were observed across all participating companies.

Conclusions:

  • Increased health risk is a substantial driver of medical expenditures across diverse corporate settings.
  • The findings support the implementation of health promotion programs to mitigate excess costs.
  • Health practitioners can confidently estimate that excess risk contributes 25-30% to annual medical costs, irrespective of industry or demographics.